Speaker Presentations
- A Prescription for Change for the FDA Bruce Psaty, M.D., Ph.D., University of Washington School of Medicine
- Incentivizing Drug Discovery and Drug Safety Alastair Wood, M.D., Symphony Capital
- FDA Reform: What are the Critical Issues? Steve Nissen, M.D., Cleveland Clinic
- Industry Funding of CME: How Drug Companies Have Taken Over Medical Education Daniel Carlat, M.D., The Carlat Psychiatry Report
- Academic Detailing for better Prescription Drug Use Frank May, M.App.Sci, Harvard Medical School
- Gathering Stakeholders around State Drug and Device Policy Mark Earnest, M.D., Ph.D., University of Colorado Denver School of Medicine
- Interactions between Industry and Academic Medical Centers: Managing the Boundaries Barbara Barnes, M.D., M.S., University of Pittsburgh Medical Center
- Creating Effective Prescriber Education and Outreach Programs Jennifer L. Reck, Policy Analyst, Prescription Policy Choices
- Challenging anti-generics legislation Mark Gibson, Oregon Health and Sciences University
- Emerging Issues: Challenging Anti-Generics Legislation Bryan R. O'Malley, Office of New York Assembly Member Richard Gottfried
- Prescription Hello: How Physician Communities can Aid State Reform Efforts Lynn Parry, M.D., Colorado Prescription Coalition
- National Physicians Alliance Christopher P. McCoy, M.D., Policy Chair, NPA
- Data mining and the First Amendment Meredith Jacob, Project on Information Justice and Intellectual Property, Washington College of Law, American University
- Data mining personal medical information to sell prescription drugs Rep. Cindy Rosenwald, New Hampshire House of Representatives
- Building a Prescription Reform Coaltion Peter Wyckoff, Prescription Project
- Case Study: Washington Coalition for Prescribing Integrity Rupin Thakkar, M.D., National Physicians Alliance
- The Colorado State Coalition: a Staffing Perspective Alicia Haywood, Colorado Prescription Coalition



